March/April 2015

5-HT3 Receptor Antagonist Effects in Cancer Patients With Multiple Risk Factors

May 15, 2015

The American Journal of Pharmacy Benefits

Palonosetron has been found to be effective in treating chemotherapy-induced nausea and vomiting, but no other studies that have compared it with the other 5-HT3 RAs are currently available.

Therapeutic Substitution From Atorvastatin to Simvastatin: Impact on LDL Control

May 12, 2015

The American Journal of Pharmacy Benefits

Evaluation of a therapeutic substitution from atorvastatin to simvastatin on low-density lipoprotein control, and assessment of program participation rates for a commercially insured population.

Implementing Guideline-Recommended Therapy for Patients With CKD: Is Hope on the Horizon?

April 23, 2015

The American Journal of Pharmacy Benefits

This commentary addresses the possible reasons for treatment gaps between recommended therapy for patients with CKD, and the realities of current practices, and examines new developments that may bridge the gap.

Medicare Part D Optimization: Potential Out-of-Pocket Savings Through Plan Reexamination

April 22, 2015

The American Journal of Pharmacy Benefits

Medicare Part D plans can change their cost-sharing structure and formularies every year. As such, beneficiaries should annually reevaluate plan offerings to minimize their out-of-pocket costs.

What Patients Want and Need From Health Exchange Plans

April 22, 2015

The American Journal of Pharmacy Benefits

Health insurance is now attainable for millions of Americans. However, research shows that patient protections must be strengthened and plan information must be made more readily accessible.

The Formularies Fight Back: AJMC Panelists Discuss How Discounts, Exclusivity Deals Should Expand HCV Treatment

April 21, 2015

The American Journal of Pharmacy Benefits

Panelists agreed that the trend of specialization of traditional drug classes has implications not only for costs, but also for the role of community pharmacy if more drugs fall into the specialty pharmacy realm.

Toward a Better Understanding of High-Risk Medications in the Elderly

April 20, 2015

The American Journal of Pharmacy Benefits

As older adults in the United States continue to take high-risk medications despite evidence of poor outcomes, plans seek quality improvement through innovative and varied strategies that include partnering with community pharmacies.